Posts

Showing posts from September, 2026

Long COVID Treatment 2026: What Randomized Clinical Trials Actually Show

Image
Long COVID remains one of the most difficult post-infectious conditions to treat because it does not behave like a single disease with one mechanism or one universally effective therapy. Patients may experience fatigue, post-exertional symptom exacerbation, brain fog, shortness of breath, sleep problems, dysautonomia, pain, palpitations, gastrointestinal symptoms and many other problems, often in combinations that differ substantially between individuals. So what treatments actually work? The most reliable way to answer that question is to examine randomized clinical trials , especially studies with appropriate control groups, clinically meaningful outcomes, adequate sample sizes and sufficient follow-up. This 2026 evidence guide reviews important randomized human studies of antiviral treatment, microbiome-targeted therapy, intermittent fasting, metformin, h...

Tick-Borne Diseases 2026: Lyme Disease, Alpha-Gal Syndrome, Symptoms, Risks & Prevention

Image
Tick-Borne Disease Guide • 2026 Update Updated: September 2026   |   Evidence review: CDC, peer-reviewed research and public-health surveillance Ticks are no longer simply an outdoor nuisance. In the United States, millions of people encounter ticks every year, while diseases and conditions associated with tick exposure include Lyme disease, Rocky Mountain spotted fever, babesiosis, ehrlichiosis, anaplasmosis, Powassan virus and alpha-gal syndrome. This 2026 guide explains what the current evidence shows, how different tick species create different risks, what symptoms to watch for, how to remove a tick safely, and how to reduce exposure. Important distinction: alpha-gal syndrome is an allergy associated with certain tick bites, not a conventional tick-borne infection. A tick bite also does not automatically mean a person has acquired an infection. ...

Labels

Show more

Archive

Show more